Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Kaufmann

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
BMC Cancer|November 6, 2014
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registryIsabell Witzel, Volkmar Müller, Wolfgang Abenhardt, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cellsTimo Faltus, Juping Yuan, Brigitte Zimmer, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2003
EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapyChristine Solbach, Marc Roller, Kai Budischewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 StudyManfred Kaufmann, Walter Jonat, Jörn Hilfrich, et al.
Cancer Research|June 3, 2006
Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivoBirgit Spänkuch, Sandra Heim, Elisabeth Kurunci-Csacsko, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2007
FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cellsBernd T Martin, Kai Kleiber, Viktor Wixler, et al.
The Lancet. Oncology|December 2, 2006
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysisWalter Jonat, Michael Gnant, Francesco Boccardo, et al.
Data in Brief|February 2, 2018
Ocean currents and acoustic backscatter data from shipboard ADCP measurements at three North Atlantic seamounts between 2004 and 2015Christian Mohn, Anneke Denda, Svenja Christiansen, et al.
Water Research|September 9, 2020
The effect of microplastics pollution in microalgal biomass production: A biochemical studyCésar Cunha, Joana Lopes, Jorge Paulo, et al.
Environmental Pollution (Barking, Essex : 1987)|July 25, 2025
Organic ultraviolet filters in the blubber of two free-ranging deep-diving cetacean speciesEva Íñiguez, Sarah Montesdeoca-Esponda, Filipe Alves, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
BMC Cancer|November 6, 2014
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registryIsabell Witzel, Volkmar Müller, Wolfgang Abenhardt, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cellsTimo Faltus, Juping Yuan, Brigitte Zimmer, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2003
EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapyChristine Solbach, Marc Roller, Kai Budischewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 StudyManfred Kaufmann, Walter Jonat, Jörn Hilfrich, et al.
Cancer Research|June 3, 2006
Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivoBirgit Spänkuch, Sandra Heim, Elisabeth Kurunci-Csacsko, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2007
FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cellsBernd T Martin, Kai Kleiber, Viktor Wixler, et al.
The Lancet. Oncology|December 2, 2006
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysisWalter Jonat, Michael Gnant, Francesco Boccardo, et al.
Data in Brief|February 2, 2018
Ocean currents and acoustic backscatter data from shipboard ADCP measurements at three North Atlantic seamounts between 2004 and 2015Christian Mohn, Anneke Denda, Svenja Christiansen, et al.
Water Research|September 9, 2020
The effect of microplastics pollution in microalgal biomass production: A biochemical studyCésar Cunha, Joana Lopes, Jorge Paulo, et al.
Environmental Pollution (Barking, Essex : 1987)|July 25, 2025
Organic ultraviolet filters in the blubber of two free-ranging deep-diving cetacean speciesEva Íñiguez, Sarah Montesdeoca-Esponda, Filipe Alves, et al.
Pageof 15